Catalyst Wire Dossier Catalyst Wire Dossier

AlloMend Acellular Dermal Matrix Allograft

· AlloSource
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AlloMend Acellular Dermal Matrix Allograft, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

See pricing